Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.23 +0.05 (+4.42%)
As of: Oct 21, 2026 · 9:44 AM EDT

Chemomab Therapeutics (CMMB) Receivables - Net (2011 - 2019)

Updated

Chemomab Therapeutics' Receivables - Net came in at $408,000 for Q4 2019, down 88.0% from $3.4 million a year earlier and down 67.0% from the prior quarter.

Analysis

Chemomab Therapeutics (CMMB) Receivables - Net (2011 - 2019) Analysis & Trends

Going back to Q4 2017, Chemomab Therapeutics' Receivables - Net data covers 5 quarters.

  • Going back by year, Receivables - Net was $3.4 million in FY2018 (+750.8%) and $400,000 in FY2017.
  • The Q4 2019 figure represents the lowest quarterly Receivables - Net since Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.43 Bn 1,102.02 Bn 19.71 Bn
2 Johnson & Johnson 615.31 Bn 533.83 Bn 17.26 Bn
3 AbbVie 505.93 Bn 479.05 Bn 12.70 Bn
4 Merck 367.07 Bn 321.44 Bn 12.21 Bn
5 Novartis Ag 297.69 Bn 261.68 Bn 11.24 Bn
6 Astrazeneca 261.59 Bn 235.28 Bn 12.86 Bn
7 Amgen 236.28 Bn 191.68 Bn 7.24 Bn
8 Gilead Sciences 190.31 Bn 164.51 Bn 6.22 Bn
9 Pfizer 170.69 Bn 117.33 Bn 10.94 Bn
10 Chemomab Therapeutics 7.84 Mn -27.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 408,000.00
Sep 30, 2019 1.24 Mn
Jun 30, 2019 885,000.00
Dec 31, 2018 3.40 Mn
Dec 31, 2017 400,000.00
Dec 31, 2012 356,500.48
Sep 30, 2012 219,859.07
Jun 30, 2012 247,816.37
Dec 31, 2011 569,394.10
Sep 30, 2011 394,362.41
Jun 30, 2011 219,390.74
API Access

Chemomab Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=CMMB&period=max&api_key=YOUR_API_KEY